JERSTRUQ Trademark

Trademark Overview


On Thursday, June 10, 2021, a trademark application was filed for JERSTRUQ with the United States Patent and Trademark Office. The USPTO has given the JERSTRUQ trademark a serial number of 90766054. The federal status of this trademark filing is REGISTERED as of Tuesday, April 5, 2022. This trademark is owned by Glaxo Group Limited. The JERSTRUQ trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
jerstruq

General Information


Serial Number90766054
Word MarkJERSTRUQ
Filing DateThursday, June 10, 2021
Status700 - REGISTERED
Status DateTuesday, April 5, 2022
Registration Number6693831
Registration DateTuesday, April 5, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 18, 2022

Trademark Statements


Goods and ServicesVaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 31, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Tuesday, November 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 5, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, January 18, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 18, 2022PUBLISHED FOR OPPOSITION
Wednesday, December 29, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 15, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 15, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, December 15, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 15, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, December 15, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, December 9, 2021ASSIGNED TO EXAMINER
Tuesday, August 31, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 14, 2021NEW APPLICATION ENTERED IN TRAM